IN2013MU00646A - - Google Patents
Download PDFInfo
- Publication number
- IN2013MU00646A IN2013MU00646A IN646MU2013A IN2013MU00646A IN 2013MU00646 A IN2013MU00646 A IN 2013MU00646A IN 646MU2013 A IN646MU2013 A IN 646MU2013A IN 2013MU00646 A IN2013MU00646 A IN 2013MU00646A
- Authority
- IN
- India
- Prior art keywords
- preparation
- present
- crystalline form
- provides novel
- endoxifen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
- C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
- C07C217/18—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN646MU2013 IN2013MU00646A (enEXAMPLES) | 2013-03-04 | 2014-03-03 | |
| PCT/IN2014/000136 WO2014141292A2 (en) | 2013-03-04 | 2014-03-03 | Endoxifen citrate polymorph and process for preparing the same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN646MU2013 IN2013MU00646A (enEXAMPLES) | 2013-03-04 | 2014-03-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2013MU00646A true IN2013MU00646A (enEXAMPLES) | 2015-06-26 |
Family
ID=51538243
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN646MU2013 IN2013MU00646A (enEXAMPLES) | 2013-03-04 | 2014-03-03 |
Country Status (2)
| Country | Link |
|---|---|
| IN (1) | IN2013MU00646A (enEXAMPLES) |
| WO (1) | WO2014141292A2 (enEXAMPLES) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2988620A1 (en) | 2015-06-16 | 2016-12-22 | Jiangsu Hengrui Medicine Co., Ltd. | Piperidine derivative and preparation method and pharmaceutical use thereof |
| RU2727705C1 (ru) | 2015-12-22 | 2020-07-23 | Цзянсу Хэнжуй Медицин Ко., Лтд. | Производное бензопиперидина, способ его получения и его медицинское применение |
| SG11202002105WA (en) | 2017-09-11 | 2020-04-29 | Atossa Therapeutics Inc | Methods for making and using endoxifen |
| NZ764463A (en) | 2017-11-14 | 2023-07-28 | Kind Pharmaceutical | Heterocyclic compound and application thereof in medicine |
| MX2022000203A (es) | 2019-07-03 | 2022-03-22 | Atossa Therapeutics Inc | Composiciones de liberacion sostenida de endoxifeno. |
| CN114746424B (zh) | 2020-01-10 | 2023-06-16 | 江苏恒瑞医药股份有限公司 | 三环四氢异喹啉类衍生物、其制备方法及其在医药上的应用 |
| BR112022020320A2 (pt) * | 2020-04-10 | 2022-12-13 | Jina Pharmaceuticals Inc | Método para manter uma concentração terapeuticamente eficaz de endoxifeno para tratamento de um paciente com distúrbio bipolar i |
| CA3185993A1 (en) | 2020-04-10 | 2021-10-14 | Jina Pharmaceuticals, Inc. | Endoxifen for the treatment of bipolar i disorder |
| ES3035848T3 (en) * | 2020-04-10 | 2025-09-10 | Jina Pharmaceuticals Inc | Endoxifen for the treatment of bipolar i disorder |
| EP4368624A4 (en) | 2021-07-09 | 2024-12-18 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | SALT TYPES OF A TRICYCLIC TETRAHYDROISOQUINOLINE DERIVATIVE |
| WO2023137044A2 (en) | 2022-01-12 | 2023-07-20 | Atossa Therapeutics, Inc. | Compositions of (z)-endoxifen and methods of enrichment thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW593256B (en) * | 1999-11-16 | 2004-06-21 | Hormos Medical Oy Ltd | Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| US20090291134A1 (en) * | 2006-11-21 | 2009-11-26 | Jina Pharmaceuticals, Inc. | Endoxifen methods and compositions in the treatment of psychiatric and neurodegenerative diseases |
| WO2009120999A2 (en) * | 2008-03-28 | 2009-10-01 | Olema Pharmaceuticals, Inc. | Use of an endoxifen prodrug for treatment of breast cancer |
| KR101308258B1 (ko) * | 2010-10-15 | 2013-09-13 | 씨제이제일제당 (주) | 엔독시펜의 신규한 제조 방법 |
-
2014
- 2014-03-03 IN IN646MU2013 patent/IN2013MU00646A/en unknown
- 2014-03-03 WO PCT/IN2014/000136 patent/WO2014141292A2/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2014141292A3 (en) | 2014-12-24 |
| WO2014141292A2 (en) | 2014-09-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2013MU00646A (enEXAMPLES) | ||
| IN2014CH00247A (enEXAMPLES) | ||
| MX370649B (es) | Proceso para la preparacion de teneligliptina. | |
| IN2013MU00848A (enEXAMPLES) | ||
| IL249872A0 (en) | Amorphous form of eliglostat hemetrate, preparations containing it and methods for its preparation | |
| IN2014MU00455A (enEXAMPLES) | ||
| IL245474A0 (en) | Process for the preparation of 5-fluoro-1h-pyrazoles | |
| IL245476B (en) | Process for the preparation of 5-fluoro-1h-pyrazoles | |
| IN2013MU03070A (enEXAMPLES) | ||
| MA40447A (fr) | Composition pharmaceutique orale d'isotrétinoïne | |
| MX2016015465A (es) | Composicion farmaceutica oral de isotretinoina. | |
| IN2013MU01113A (enEXAMPLES) | ||
| PL2967095T3 (pl) | Sposób wytwarzania serów o zmienionej strukturze | |
| EP3016935A4 (en) | Process for the preparation of intermediate of dolutegravir | |
| PL2964607T3 (pl) | Sposób wytwarzania halogeno-n,n-dimetylobenzyloamin | |
| MX2015011881A (es) | Proceso para la preparacion de 3,7-dimetilnonan-1-ol. | |
| IL229326A (en) | Process for making n-iodine-affluent | |
| WO2014170909A3 (en) | Process for pomalidomide | |
| IN2013MU02528A (enEXAMPLES) | ||
| IN2013MU03768A (enEXAMPLES) | ||
| MX382969B (es) | Método para producir halocetonas. | |
| IN2014CH01391A (enEXAMPLES) | ||
| IN2013MU01501A (enEXAMPLES) | ||
| IN2013MU01524A (enEXAMPLES) | ||
| IN2013CH05395A (enEXAMPLES) |